Answers are grounded in this paper and cite their sources.
Evaluates leukemia classification using five machine learning classifiers, highlighting robust performance.
This paper extends the work of Bouazza et al. (IEEE, 2015), which applied K-Nearest Neighbor (KNN) and Support Vector Machine (SVM) classifiers with filter-based feature selection to classify gene expression microarray data for leukemia, prostate, and colon cancer. Our extension focuses exclusively on the Golub 1999 leukemia dataset (72 samples, 7,129 genes; ALL vs. AML classification) and makes four primary contributions over the base paper: (1) three additional classifiers — Logistic Regression (LR), Decision Tree (DT), and Naive Bayes (NB) — completing the five-classifier ML evaluation pipeline; (2) K-parameter optimization (K = 1–20) not present in the original; (3) 10-fold stratified cross-validation replacing the single train-test split; and (4) comprehensive evaluation metrics including Precision, Recall, F1-Score, and Confusion Matrix. Signal-to-Noise Ratio (SNR) feature selection retaining the top 30 genes is preserved from the original paper for reproducibility. On the 15-sample held-out test set, KNN (K=1), SVM, Logistic Regression, and Naive Bayes each achieved 100% accuracy; Decision Tree achieved 86.67% (F1: 83.33%). Under 10-fold cross-validation, SVM, Logistic Regression, and Naive Bayes achieved a mean accuracy of 95.71% ± 9.15%, confirming robust generalizability. PCA visualization confirms clear class separation (PC1 + PC2 = 62.5% variance). Results demonstrate that the original SNR-based methodology is reproducible and that multiple classifiers achieve equivalent discriminative performance on this dataset.
No takes yet. Share an insight, caveat, or question.
Abhishek Raj Urs K S (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: